A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria - PubMed (original) (raw)
Case Reports
. 1990 Jul;150(7):1469-74.
Affiliations
- PMID: 2196028
Case Reports
A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria
K E Anderson et al. Arch Intern Med. 1990 Jul.
Abstract
Acute intermittent porphyria is a genetic disease in which endogenous hormones affect clinical expression. Premenstrual exacerbations can occur, sometimes often, in women with this disease. Gonadotropin releasing hormone analogues can prevent ovulation by reducing secretion of luteinizing hormone and follicle-stimulating hormone. In six patients with well-documented acute intermittent porphyria and frequent cyclical exacerbations, daily administration of an agonistic gonadotropin releasing hormone analogue, ([ImBzl]-D-His6,Pro9-NET)gonadotropin releasing hormone, intranasally or subcutaneously for as long as 26 months reduced or eliminated premenstrual attacks and caused only minor side effects. Adjustments in dosage or route of administration were sometimes needed. We conclude that endocrine manipulation by treatment with a gonadotropin releasing hormone agonist will prevent neurovisceral attacks of acute intermittent porphyria due to cyclical changes in endogenous hormones and is a safe alternative to exogenous steroids, which may induce attacks of this disease.
Similar articles
- Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone.
Anderson KE, Spitz IM, Sassa S, Bardin CW, Kappas A. Anderson KE, et al. N Engl J Med. 1984 Sep 6;311(10):643-5. doi: 10.1056/NEJM198409063111006. N Engl J Med. 1984. PMID: 6433194 No abstract available. - LHRH analogues for hormonal manipulation in acute intermittent porphyria.
Anderson KE. Anderson KE. Semin Hematol. 1989 Jan;26(1):10-5. Semin Hematol. 1989. PMID: 2646719 Review. - Therapeutic uses of gonadotropin-releasing hormone analogs.
Andreyko JL, Marshall LA, Dumesic DA, Jaffe RB. Andreyko JL, et al. Obstet Gynecol Surv. 1987 Jan;42(1):1-21. Obstet Gynecol Surv. 1987. PMID: 3543765 Review. - LHRH analogue treatment for the prevention of premenstrual attacks of acute porphyria.
Herrick AL, McColl KE, Wallace AM, Moore MR, Goldberg A. Herrick AL, et al. Q J Med. 1990 Apr;75(276):355-63. Q J Med. 1990. PMID: 2117297 Clinical Trial.
Cited by
- RNA interference therapy in acute hepatic porphyrias.
Yasuda M, Keel S, Balwani M. Yasuda M, et al. Blood. 2023 Nov 9;142(19):1589-1599. doi: 10.1182/blood.2022018662. Blood. 2023. PMID: 37027823 Free PMC article. - Prevalence of Undiagnosed Acute Hepatic Porphyria in Cyclic Vomiting Syndrome and Overlap in Clinical Symptoms.
Cheng S, Yu E, Garacci Z, Erwin AL, Venkatesan T. Cheng S, et al. Dig Dis Sci. 2023 May;68(5):2107-2114. doi: 10.1007/s10620-022-07756-6. Epub 2022 Nov 16. Dig Dis Sci. 2023. PMID: 36380150 - Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review.
Ramai D, Deliwala SS, Chandan S, Lester J, Singh J, Samanta J, di Nunzio S, Perversi F, Cappellini F, Shah A, Ghidini M, Sacco R, Facciorusso A, Giacomelli L. Ramai D, et al. Cancers (Basel). 2022 Jun 15;14(12):2947. doi: 10.3390/cancers14122947. Cancers (Basel). 2022. PMID: 35740611 Free PMC article. Review. - Prophylactic Heme Arginate Infusion for Acute Intermittent Porphyria.
Kuo HC, Lin CN, Tang YF. Kuo HC, et al. Front Pharmacol. 2021 Oct 6;12:712305. doi: 10.3389/fphar.2021.712305. eCollection 2021. Front Pharmacol. 2021. PMID: 34690757 Free PMC article. - The acute hepatic porphyrias.
Wang B. Wang B. Transl Gastroenterol Hepatol. 2021 Apr 5;6:24. doi: 10.21037/tgh-2020-01. eCollection 2021. Transl Gastroenterol Hepatol. 2021. PMID: 33824928 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical